Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery.
10.17245/jdapm.2016.16.3.151
- Author:
Kyung Soo PARK
1
;
Chi Heun LEE
;
Jung Woo LEE
Author Information
1. Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Seoul, Korea. omsace@gmail.com
- Publication Type:Review
- Keywords:
Botulinum toxin;
Botulinum toxin, type A;
Dentistry;
Oral and Maxillofacial Surgeons
- MeSH:
Anesthesiology;
Botulinum Toxins*;
Dentistry*;
Humans;
Hypertrophy;
Masticatory Muscles;
Oral and Maxillofacial Surgeons;
Serogroup;
Surgery, Oral*;
Temporomandibular Joint Disorders
- From:Journal of Dental Anesthesia and Pain Medicine
2016;16(3):151-157
- CountryRepublic of Korea
- Language:English
-
Abstract:
Botulinum toxin (BT) was the first toxin to be used in the history of human medicine. Among the eight known serotypes of this toxin, those currently used in medicine are types A and B. This review article mainly discusses BT type A (BTA) because it is usually used in dentistry including dental anesthesiology and oral and maxillofacial surgery. BTA has been used mainly in the treatment of temporomandibular joint disorder (TMD) and hypertrophy and hyperactivity of the masticatory muscles, along with being a therapeutic option to relieve pain and help in functional recovery from dental and oral and maxillofacial surgery. However, it is currently used broadly for cosmetic purposes such as reducing facial wrinkles and asymmetry. Although the therapeutic effect of BTA is temporary and relatively safe, it is essential to have knowledge about related anatomy, as well as the systemic and local adverse effects of medications that are applied to the face.
